AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.00322
0.00 (0.00%)
At close: Nov 9, 2026

AXIM Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
155605423
Market Cap Growth
-67.12%-12.57%-91.35%10.19%135.52%-48.38%
Enterprise Value
-1011665929
Last Close Price
0.000.020.030.430.430.36

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
12.59114.26581.91987.63--
PB Ratio
--0.59-1.07-25.5434.61-3.40

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
-260.761201.771086.71--

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.71-0.77-1.18-2.894.05-0.75
Net Debt / Equity Ratio
-0.71-0.75-1.17-2.693.75-0.65
Net Debt / EBITDA Ratio
-3.60-2.47-1.33-1.07-1.19-1.41
Net Debt / FCF Ratio
-8.89-5.57-2.75-2.49-1.77-0.87
Asset Turnover
0.020.010.000.01--
Quick Ratio
0.000.030.010.180.310.21
Current Ratio
0.000.030.030.250.480.48
Return on Assets (ROA)
-36.27%-41.26%-60.99%-60.17%-47.56%-102.77%
Return on Capital Employed (ROCE)
81.30%148.10%-567.70%-292.00%-50.40%182.50%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-638.82%-178.50%-120.88%-26.85%-11.83%-28.02%
FCF Yield
-65.15%-22.82%-39.75%-4.23%-6.11%-21.90%
Buyback Yield / Dilution
-27.42%-37.60%-25.79%-19.16%-78.19%-8.14%